Skip to main content
. 2017 Aug 9;7:7650. doi: 10.1038/s41598-017-07933-y

Figure 11.

Figure 11

Pentabromopseudilin-mediated inhibition of steady-state ATPase activities for WT and mutant constructs. Inhibition profile of the actin-activated ATPase activity (20 µM F-actin) of WT and mutant myosins by 100 µM PBP. Numbers on top indicate the extent of inhibition (n-fold change) compared to the 5% DMSO control. Data are mean values of 3–5 independent measurements and error bars give the standard deviation. The differences between DMSO control and PBP were significant in all cases (p < 0.05).